FDA — authorised 29 December 1989
- Marketing authorisation holder: MALLINCKRODT LLC
- Status: approved
FDA authorised Anafranil on 29 December 1989
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 29 December 1989.
MALLINCKRODT LLC holds the US marketing authorisation.